Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

ExcitePCR Announces its Board of Advisors
  • USA - English


News provided by

ExcitePCR

Sep 26, 2017, 07:35 ET

Share this article

Share toX

Share this article

Share toX

R. Paul Schaudies, Ph.D. has joined the ExcitePCR Advisory Board
R. Paul Schaudies, Ph.D. has joined the ExcitePCR Advisory Board

Pleasanton, Calif. (PRWEB) September 26, 2017 -- ExcitePCR today announced it has formed a Board of Advisors, with Dr. R. Paul Schaudies, Charles Pick and Anilrudh Venugopal, MD accepting advisory roles with the company.

Industry expertise for these advisors stretches from agricultural genomics to biodefense and from molecular diagnostics to infectious diseases.

These highly regarded industry experts will help us accelerate our commercialization efforts and go-to-market strategies at ExcitePCR.

Post this

“These highly regarded industry experts will help us accelerate our commercialization efforts and go-to-market strategies at ExcitePCR,” said Lyle L. Probst, CEO, President and Founder of ExcitePCR. “I believe their relevant experience, insights and relationships enhance our ability to execute our FireflyDX™ plans as we look to help save lives and lower costs in the healthcare, first responder, agricultural and food industries.”

About Paul Schaudies, Ph.D.
R. Paul Schaudies, Ph.D. is an internationally recognized expert in biodefense, biotechnology and nanotechnology, and he is the CEO and Co-founder of GenArraytion, a molecular diagnostics company. Dr. Schaudies was the science advisor to the U.S. Environmental Protection Agency (EPA) On-Scene Coordinator, as well as the Incident Commander of the 2001 anthrax incident in Washington, D.C. As a U.S. Army Officer, he supported the United Nations as an UNSCOM inspector in Iraq. Dr. Schaudies was also an AVP and Division Manager for Biological and Chemical Defense at Science Applications International Corporation (SAIC) for nine years, and he spent 13 years as an active duty U.S. Army officer before he retired as a Lieutenant Colonel. In addition, Dr. Schaudies was the Program Manager for Biological and Chemical Defense Research in the Central MASINT Office at the U.S. Defense Intelligence Agency (DIA), and he served as a Senior Researcher at the Walter Reed Army Institute of Research where he authored over 25 peer-reviewed scientific publications.

About Charles Pick
Charles Pick has over 25 years of experience in the agriculture and biotechnology industries and is the President of seqID, a firm that specializes in agricultural genomic technologies. Pick received a bachelor’s degree in Immunology at the University of Toronto and an MBA degree from the Smith School of Business at Queens University in Kingston, Ontario. He began his career in the seed industry becoming VP of Canadian turf operations at the Pickseed Companies Group before serving as head of business development for BASF’s agricultural genomics division (DNA LandMarks) for 11 years. Pick launched seqID in 2014 with the aim of bringing the latest genomic technologies and services to the agricultural sector.

About Anilrudh Venugopal, MD
Anilrudh Venugopal, MD is a board-certified Infectious Diseases and Internal Medicine physician with over 15 years of clinical experience. He previously held academic faculty appointments at the Wayne State School of Medicine and the Loyola University Chicago Stritch School of Medicine. Dr. Venugopal has a strong research background and has authored numerous publications and presentations on MRSA (Methicillin-resistant Staphylococcus aureus) and Clostridium difficile (C. diff.) infections. He also consults with pharmaceutical and medical device companies to assess the potential impact of their products and helps develop strategy to target and bring products to market.

Last month ExcitePCR announced its FireflyDX family of portable pathogen detection systems, led by its FireflyDX-Portable™, a rechargeable bookbag-sized realtime pathogen detection system the company says will be commercially available in summer 2018. Key among the benefits of the FireflyDX-Portable is its ability to provide highly accurate, PCR-based pathogen identification in 30 minutes or less anywhere on the planet at the Point-of-Care/Point-of-Need (POC/PON), including sample preparation time.

About ExcitePCR
Headquartered in Pleasanton, California, ExcitePCR Corporation is developing portable pathogen detection systems based upon superior sample preparation and realtime PCR (Polymerase Chain Reaction) methodologies. Its FireflyDX technologies will deliver rapid automated Point-of-Care/Point-of-Care (POC/PON) sample preparation and highly accurate biohazard identification in a fraction of the time currently possible using existing PCR-based solutions.

ExcitePCR, FireflyDX and FireflyDX-Portable are each trademarks of ExcitePCR Corporation. All other trademarks are the property of their respective owners.

CONTACT: David Politis, dpolitis(at)excitepcr(dot)com, C: 801-556-8184

David Politis, ExcitePCR, http://www.excitepcr.com, +1 801-556-8184, [email protected]

Modal title

Charles Pick has been named to the ExcitePCR Advisory Board
Charles Pick has been named to the ExcitePCR Advisory Board
Anilrudh Venugopal, MD has joined the ExcitePCR Advisory Board
Anilrudh Venugopal, MD has joined the ExcitePCR Advisory Board
ExcitePCR's logo
ExcitePCR's logo
Charles Pick has been named to the ExcitePCR Advisory Board Anilrudh Venugopal, MD has joined the ExcitePCR Advisory Board ExcitePCR's logo

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.